Different patterns of stromal and cancer cell thymidine phosphorylase reactivity in non-small-cell lung cancer: impact on tumour neoangiogenesis and survival

被引:106
|
作者
Koukourakis, MI [1 ]
Giatromanolaki, A
Kakolyris, S
O'Byrne, KJ
Apostolikas, N
Skarlatos, J
Gatter, KC
Harris, AL
机构
[1] Univ Hosp Irakl, Dept Radiotherapy Oncol, Iraklion 71110, Greece
[2] Univ Hosp Irakl, St Nikolas Histopathol Unit, Iraklion 71110, Greece
[3] Oxford Radcliffe Hosp, Dept Cellular Sci, Oxford OX3 7LJ, England
[4] Oxford Radcliffe Hosp, Dept ICRF, Med Oncol Unit, Oxford OX3 7LJ, England
[5] Hellen Canc Inst, Dept Radiat Oncol, Athens, Greece
[6] Hellen Canc Inst, Dept Histopathol, Athens, Greece
关键词
PD-ECGF; thymidine phosphorylase fibroblast; macrophage; lung cancer;
D O I
10.1038/bjc.1998.280
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Angiogenesis is recognized as an important step in tumour pathogenesis that is related to invasion and metastatic spread and which consequently results in poor clinical outcome. In this study, we have examined the role of tumour stroma-activated fibroblasts and macrophage infiltration in the development of the angiogenic and metastatic phenotype in non-small-cell lung cancer (NSCLC). A total of 141 cases of early stage I-Il NSCLC treated with surgery alone were analysed. The JC-70 (anti-CD31) MAb was used for the assessment of vascular grade. The P-GF.44C MAb was used to assess thymidine phosphorylase (TP) reactivity in cancer cells, stromal fibroblasts and macrophages, Cancer cell TP overexpression related to high vascular grade and to advanced T stage (P = 0.0004 and P = 0.02). Expression of TP in stromal fibroblasts also correlated with high angiogenesis (P = 0.01), but was independent of cancer cell expression. Fibroblast TP overexpression was related to abundant stroma (P=0.003), suggesting that TP may be a marker of active stroma, Moreover, intense macrophage infiltration was associated with fibroblast TP reactivity, regardless of the amount of stroma, suggesting that macrophages may be a major contributor to TP expression in stroma. Survival analysis showed that cancer cell TP overexpression was related to poor prognosis (P = 0.005). Although stroma TP is related to angiogenesis, in the low vascular grade group it defined a group of patients with better prognosis (P = 0.02). It may be that fibroblast TP reactivity is an indirect marker of tumour infiltration by functional macrophages, which have an anti-tumour effect, We conclude that stromal macrophage and fibroblast TP reactivity may have an important role in non-small-cell lung cancer behaviour. Understanding the role of stromal fibroblasts and inflammatory cells and their interaction with oncoprotein expression is essential for the elucidation of lung cancer pathogenesis.
引用
收藏
页码:1696 / 1703
页数:8
相关论文
共 50 条
  • [1] Different patterns of stromal and cancer cell thymidine phosphorylase reactivity in non-small-cell lung cancer: impact on tumour neoangiogenesis and survival
    MI Koukourakis
    A Giatromanolaki
    S Kakolyris
    KJ O'Byrne
    N Apostolikas
    J Skarlatos
    KC Gatter
    AL Harris
    British Journal of Cancer, 1998, 77 : 1696 - 1703
  • [2] Impact of different patterns of metastasis in non-small-cell lung cancer patients
    da Silva, Larissy Machado
    da Silva, Gustavo Telles
    Bergmann, Anke
    Costa, Guilherme Jorge
    Zamboni, Mauro Musa
    Santos Thuler, Luiz Claudio
    FUTURE ONCOLOGY, 2021, 17 (07) : 775 - 782
  • [3] Proteomic patterns of tumour subsets in non-small-cell lung cancer
    Yanagisawa, K
    Shyr, Y
    Xu, BGJ
    Massion, PP
    Larsen, PH
    White, BC
    Roberts, JR
    Edgerton, M
    Gonzalez, A
    Nadaf, S
    Moore, JH
    Caprioli, RM
    Carbone, DP
    LANCET, 2003, 362 (9382): : 433 - 439
  • [4] Maintenance therapy with pemetrexed in non-small-cell lung cancer: Impact on survival
    Vaz, Daniel
    Campainha, Sergio
    Antunes, Ana
    Conde, Sara
    Barroso, Ana
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [5] Impact of a Contralateral Tumor Nodule on Survival in Non-Small-Cell Lung Cancer
    Morris, Zachary S.
    Cannon, Donald M.
    Morris, Brett A.
    Bentzen, Soren M.
    Kozak, Kevin R.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (11) : 1608 - 1615
  • [6] Neoangiogenesis: A putative marker of malignancy in non-small-cell lung cancer (NSCLC) development
    Fontanini, G
    Vignati, S
    Bigini, D
    Lucchi, M
    Mussi, A
    Basolo, F
    Angeletti, CA
    Bevilacqua, G
    INTERNATIONAL JOURNAL OF CANCER, 1996, 67 (05) : 615 - 619
  • [7] 'Tumour volume' as a predictor of survival after resection of non-small-cell lung cancer (NSCLC)
    Jefferson, MF
    Pendleton, N
    Faragher, EB
    Dixon, GR
    Myskow, MW
    Horan, MA
    BRITISH JOURNAL OF CANCER, 1996, 74 (03) : 456 - 459
  • [8] Non-Small-Cell Lung Cancer
    不详
    GENETIC ENGINEERING & BIOTECHNOLOGY NEWS, 2008, 28 (20): : 61 - 61
  • [9] Non-small-cell lung cancer
    Cesare Gridelli
    Antonio Rossi
    David P. Carbone
    Juliana Guarize
    Niki Karachaliou
    Tony Mok
    Francesco Petrella
    Lorenzo Spaggiari
    Rafael Rosell
    Nature Reviews Disease Primers, 1
  • [10] Non-small-cell lung cancer
    Gridelli, Cesare
    Rossi, Antonio
    Carbone, David P.
    Guarize, Juliana
    Karachaliou, Niki
    Mok, Tony
    Petrella, Francesco
    Spaggiari, Lorenzo
    Rosell, Rafael
    NATURE REVIEWS DISEASE PRIMERS, 2015, 1